<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 10, 2000
GENELABS TECHNOLOGIES, INC.
---------------------------
(Exact name of Registrant as specified in charter)
CALIFORNIA
----------
(State or other jurisdiction of incorporation)
<TABLE>
<S> <C>
0-19222 94-3010150
------- ----------
(Commission file number) (IRS employer
identification no.)
505 PENOBSCOT DRIVE, REDWOOD CITY, CALIFORNIA 94063
--------------------------------------------- -----
(Address of principal executive offices) (Zip code)
</TABLE>
(650) 369-9500
--------------
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 5. OTHER EVENTS.
On July 10, 2000, Acqua Wellington North American Equities Fund, Ltd. ("Acqua
Wellington") and Genelabs Technologies, Inc. ("Genelabs") entered into an
agreement for an equity financing facility covering the sale of up to $29
million of Genelabs common stock. Under this agreement, Acqua Wellington will
make an initial investment of $4 million through a purchase of 1,000,000 shares
of Genelabs' common stock, registered under Genelabs Registration Statement on
Form S-3 Number 333-34630. Genelabs may sell additional shares to Acqua
Wellington over the next 18 months, at Genelabs' discretion, at discounts
ranging from 3.5% to 6% of the market price at the time of sale. The total
amount of the investment will be dependent, in part, on Genelabs' stock price,
with Genelabs controlling the amount and timing of the stock sold. Under the
terms of the agreement, Genelabs pays no fees or other compensation and issues
no warrants in connection with the sale of stock.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- -----------
<S> <C>
99.1 Form of Common Stock Purchase Agreement, dated as of July 10, 2000, by
and between Genelabs Technologies, Inc. and Acqua Wellington North
American Equities Fund, Ltd.
99.2 Press Release dated July 11, 2000
</TABLE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Genelabs Technologies, Inc.
Dated: July 10, 2000 By: /s/ RICHARD A. WALDRON
-------------------------------------
Richard A. Waldron
Vice President and Chief
Financial Officer
